Kite Pharma’s ASCO ads aim to prep docs on CAR-T ahead of FDA approval – FiercePharma
FiercePharma |
Kite Pharma’s ASCO ads aim to prep docs on CAR–T ahead of FDA approval
FiercePharma Kite Pharma is hoping to bring the first CAR–T drug to the U.S. this year with its candidate KTE-C19. Kite began its rolling submission with the FDA in early December for an indication in relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma … |
FiercePharma |
Kite Pharma’s ASCO ads aim to prep docs on CAR–T ahead of FDA approval
FiercePharma Kite Pharma is hoping to bring the first CAR–T drug to the U.S. this year with its candidate KTE-C19. Kite began its rolling submission with the FDA in early December for an indication in relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma … |
|
Zika virus requires a fetal neural stem cell protein to replicate
Chemical & Engineering News The Zika virus outbreak in the Americas has revealed the devastating effects of the pathogen on developing fetal brains. Researchers are still trying to tease apart the precise mechanisms the virus uses to cross the placental barrier and cause … |
New Atlas |
Gene therapy could wipe immune memory and “turn off” severe allergies
New Atlas Scientists may be one step closer to discovering a way to genetically “turn off” allergic responses with a single injection. A team of researchers at the University of Queensland has developed a new process that has successfully silenced a severe … A new gene therapy may help ‘turn off’ asthma and food allergies …Hindustan Times New gene therapy may ‘turn off’ asthma – The Economic TimesEconomic Times Scientists may be able to trick your genes into turning off allergies, and this could be so awesomeHelloGiggles |
Peoria Journal Star |
Stark County teen’s stem cell treatment ‘going in the right direction’
Peoria Journal Star TOULON — A large benefit auction and dinner Friday evening will raise funds to help cover medical expenses for a Stark County teenager who is undergoing experimental stem cell treatment for a debilitating autoimmune disorder. Proceeds of the event to … |